Perspecta (PRSP) Tops Q1 EPS by 2c, Offers FY Guidance

Perspecta (NYSE: PRSP) reported Q1 EPS of $0.47, $0.02 better than the analyst estimate of $0.45. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.07 billion.

GUIDANCE:

Perspecta sees FY2021 EPS of $1.90-$2.03, versus the consensus of $1.95. Perspecta sees FY2021 revenue of $4.26-4.41 billion, versus the consensus of $4.32 billion.

For earnings history and earnings-related data on Perspecta (PRSP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c